COMMUNIQUÉS West-GlobeNewswire

Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy
18/09/2025
CAMBRIDGE, United Kingdom and MONTREAL, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the [...]
Epitopea renforce son comité consultatif scientifique avec la nomination de quatre experts de renommée mondiale en immunologie et immunothérapie du cancer
18/09/2025
CAMBRIDGE, ROYAUME-UNI et MONTRÉAL, 18 sept. 2025 (GLOBE NEWSWIRE) -- Epitopea, une société transatlantique spécialisée dans l'immunothérapie anticancéreuse qui développe des immunothérapies accessibles et prêtes à l' [...]
Imprivata, éditeur international de solutions de gestion des accès, se développe sur le marché français pour répondre à la demande croissante en matière de sécurité et de conformité
18/09/2025
Initialement axées sur les soins de santé, les solutions Imprivata permettent un accès clinique rapide et sécurisé aux services informatiques afin de soutenir le programme CaRE et en particulier le domaine HospiConnect [...]
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
18/09/2025
Detailed results from clinical feasibility studies show immediate improvement in blood pressure stability and durable reduction of hypotensive symptoms, resulting in improved quality of life Most people living with [...]
89bio, Inc. Announces Agreement to be Acquired by Roche
18/09/2025
– 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $6.00 per share in cash [...]
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
18/09/2025
89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most prevalent comorbidities of obesity Acquisition [...]
Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets
18/09/2025
Press Release 42% reduction in Scope 1 and 2 Greenhouse Gas emissions by 2030 (vs. 2022) 25% reduction in Scope 3 GHG emissions by 2030 (vs. 2022) September 18, 2025 - EUROAPI’s near-term science-based emission [...]
Climat : la Science Based Targets initiative (SBTi) valide les objectifs à court terme d’EUROAPI
18/09/2025
Communiqué de presse Réduction de 42% des émissions de gaz à effet de serre des Scopes 1 et 2 d’ici à 2030 (par rapport à 2022) Réduction de 25% des émissions de gaz à effet de serre du Scope 3 d’ici à 2030 (par rapport [...]
Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025
18/09/2025
SHANGHAI, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, was recognized as an “Outstanding Growth Story in Hong Kong [...]
EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future
18/09/2025
EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future The two companies continue to grow their wearables lineup with new products revealed at Meta [...]
EssilorLuxottica: Le partenariat EssilorLuxottica et Meta se poursuit avec de nouvelles lunettes avec IA qui préfigurent le futur
18/09/2025
Le partenariat EssilorLuxottica et Meta se poursuit avec de nouvelles lunettes avec IA qui préfigurent le futur Les deux groupes élargissent leur gamme de « wearables » avec de nouveaux produits dévoilés lors de Meta [...]
Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management
18/09/2025
SHANGHAI, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, received the “Excellence Award” at Gilead Sciences, Inc.’s (“ [...]
Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device
18/09/2025
Please click here to view image CARLSBAD, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional [...]
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
17/09/2025
Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ® ) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg also demonstrated [...]
Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering
17/09/2025
SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) (“Bionano” or the “Company”) today announced the closing of its previously announced public offering of an aggregate of 5,000,000 [...]
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
17/09/2025
WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the availability of proxy materials for its 2025 Annual Meeting of [...]
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
17/09/2025
Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional cost optimization measures expected to realize total annual savings of more than $100 million [...]
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
17/09/2025
Postpartum depression is a leading cause of maternal mortality in Europe 1-2 , and is one of the most common medical conditions associated with pregnancy 3-5 ; up to 20% of women experience postpartum depressive [...]
CooperCompanies Announces Expanded Share Repurchase Program
17/09/2025
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s [...]

Pages